Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 14 Lymphoma, Non-Hodgkin 10 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 7 Arthritis, Rheumatoid 7 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, B-Cell 5 Lymphoma 5 Solid Tumors 4 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Melanoma 4 Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Colorectal Neoplasms 4 Ovarian Neoplasms 3 Lymphoma, Follicular 3 Leukemia 3 Hematologic Neoplasms 3 Cytokine Release Syndrome 3 Burkitt Lymphoma 3 Urinary Bladder Neoplasms 2 Respiratory Distress Syndrome 2 Pancreatic Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Mantle-Cell 2 Fallopian Tube Neoplasms 2 Craniopharyngioma 2 Carcinoma, Hepatocellular 2

Interventions

Cisplatin 8 Carboplatin 8 Bevacizumab 8 Pleurodesis 7 Talc 6 Paclitaxel 6 Docetaxel 5 Povidone-Iodine 4 Doxycycline 4 Thoracoscopy 3 Taxes 3 Gemcitabine 3 Drug Therapy 3 Chest Tubes 3 aldesleukin 2 Zoledronic Acid 2 Trastuzumab 2 Thoracentesis 2 Surveys and Questionnaires 2 Sodium Chloride 2 Silver Nitrate 2 Pharmaceutical Preparations 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 High-Energy Shock Waves 2 Fluorodeoxyglucose F18 2 Fentanyl 2 Erlotinib Hydrochloride 2 Cetuximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pleural Effusion, Malignant × tocilizumab × Clear all

NCT06016179 2025-05-22

RIOT2

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡